HilleVax Inc logo

HilleVax Inc

NAS:HLVX (USA)  
$ 12.83 -0.13 (-1%) 11:08 PM EST
P/E:
At Loss
P/B:
2.30
Market Cap:
$ 621.19M
Enterprise V:
$ 432.37M
Volume:
36.82K
Avg Vol (2M):
64.33K
Volume:
36.82K
Market Cap $:
621.19M
PE Ratio:
At Loss
Avg Vol (2M):
64.33K
Enterprise Value $:
432.37M
PB Ratio:
2.30

Business Description

Description
HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.
Name Current Vs Industry Vs History
Cash-To-Debt 4.99
Equity-to-Asset 0.76
Debt-to-Equity 0.22
Debt-to-EBITDA -0.54
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 28.17
9-Day RSI 39.42
14-Day RSI 43.25
6-1 Month Momentum % -25.69
12-1 Month Momentum % -29.46

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 13.8
Quick Ratio 13.8
Cash Ratio 13.31

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % 12.24
Name Current Vs Industry Vs History
ROE % -35.16
ROA % -29.59
ROIC % -369.74
ROC (Joel Greenblatt) % -360.96
ROCE % -30.53

Financials (Next Earnings Date:2023-11-10 Est.)

HLVX's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:HLVX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

HilleVax Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -2.46
Beta 0
Volatility % 45.73
14-Day RSI 43.25
14-Day ATR ($) 0.86744
20-Day SMA ($) 13.4365
12-1 Month Momentum % -29.46
52-Week Range ($) 11.35 - 23.1
Shares Outstanding (Mil) 48.42

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

HilleVax Inc Filings

Filing Date Document Date Form
No Filing Data

HilleVax Inc Stock Events

Event Date Price($)
No Event Data

HilleVax Inc Frequently Asked Questions

What is HilleVax Inc(HLVX)'s stock price today?
The current price of HLVX is $12.83. The 52 week high of HLVX is $23.10 and 52 week low is $11.35.
When is next earnings date of HilleVax Inc(HLVX)?
The next earnings date of HilleVax Inc(HLVX) is 2023-11-10 Est..
Does HilleVax Inc(HLVX) pay dividends? If so, how much?
HilleVax Inc(HLVX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1